Blood Pressure
Titration Protocol for the Diabetes Planned Visit
Diabetes planned
visits address several health topics of concern to the diabetic patient,
including high blood pressure. This document provides guidance for prescribing
medication to control blood pressure.
Blood Pressure Titration Protocol
______________________________
_________________
Patient
Chart
number
Check
appropriate option below, sign and date
Complete
Physician Actions
Complete
and sign BP Titration Protocol Flow Sheet
|
|
___ Hydrochlorothiazide (HCTZ)
Diabetics treated with HCTZ
have an average increase in fasting glucose of 5 mg/dL.
Preferred first line agent
Avoid if GFR <30
- Write
prescription: HCTZ
12.5mg One daily # 30
- Write lab prescription: BMP Q week RF X
3 months Dx Hypertension
- Instruct patient
to Check BMP after taking HCTZ for 2 to 3 weeks
- Schedule Nurse
BP visit 4 weeks after starting HCTZ
- Notify clinician
if BP not at goal
- If not at goal,
avoid increasing above 12.5mg HCTZ; add another agent
___________________________________________________________________________
Physician
signature Date
|
|
___ ACE inhibitor: captopril [Capoten], enalapril
[Vasotec], lisinopril [Zestril], quinapril [Accupril], ramipril [Altace], or
___ ARB losartan [Cozaar], candesartan
[Atacand], olmesartan [Benicar], valsartan [Diovan], irbesartan [Avapro], telmisartan [Micardis], eprosartan [Teveten])
Physician
actions for ACE/ARB
- Write
prescription ACE/ARB Take as directed #60 RF x3
- Write
prescription BMP
Q week X 6 months Dx: Hypertension
- Record target
dose for ACE/ARB above (e.g., Lisinopril 20mg/day)
- Calculate and
record creatinine level 30% above baseline
- RN instructs
patient to start ACE/ARB per dose recommendations below
- RN instructs
patient to Check BMP after taking ACE/ARB for 1 week
- RN schedules Nurse
BP visit after patient takes new dose of ACE/ARB for 2 weeks
- If BP or
medication dosage not at goal, and BMP within parameters:
- Nurse increases
dose per recommendations below
- Nurse instructs
patient to get BMP one week after new dose
- Nurse instructs
patient for nurse BP visit two weeks after new dose
___________________________________________________________________________
Physician
signature Date |
|
___ Beta blocker (BB)
- Preferred 3rd agent if history of CAD, MI, CABG, angioplasty
- Avoid BB if
severe, uncontrolled bronchospastic illness (asthma, COPD)
- β1
selective BBs (atenolol,
metoprolol) are safe if used with caution in patients with asthma, COPD, peripheral vascular disease
- COPD patients
treated with BB show decreased risk of CV death
- Partial β agonist BB (labetalol) may
slow heart rate less
- BB can reduce GFR
Physician
actions for BB
- Record BP goal
- Record Dosage
goal
Nursing
actions for BB
- Nurse BP visit
every 2 weeks X 6 as needed
- Nurse checks BP
and heart rate
- Nurse monitors for
possible BB Adverse Effects
- Adverse effects:
shortness of breath, edema, fatigue, insomnia, cold extremities
- Notify physician
if HR <60, possible adverse effects, or patient reaches BP goal
- If BP or
medication dose not at goal, and HR >60, and no adverse effects, then:
- RN instructs
patient to increase dose per recommendations below
___________________________________________________________________________
Physician
signature Date |
|
Calcium
Channel Blocker
___ Long-acting non-dihydropyridine channel
blocker (CCB) (e.g., verapamil, diltiazem)
Contraindications:
- AV node
dysfunction with second or third degree AV block
- Heart failure
- Severely decreased
LV function
___ Long acting dihydropyridine CCB
(e.g. amlodipine, felodipine, isradipine,
nicardipine, nifedipine, nisoldipine)
Physician
actions for CCB
- Record BP goal
- Record dosage
goal
Nursing
actions for CCB
- Nurse BP visit
every 2 weeks X 6 as needed
- Nurse checks BP
and heart rate
- Nurse monitors
for CCB adverse effects
- Adverse effects:
Shortness of breath, edema, fatigue, slow heart rate, heart block, constipation, nausea,
headache
- Nurse notifies
physician if HR <60, possible adverse effects, or patient reaches BP goal
- If BP not at
goal, HR >60, and no adverse effects:
- RN instructs
patient to increase dose per recommendations below
___________________________________________________________________________
Physician
signature Date
|
Return to Diabetes Planned Visit Notebook Contents
Proceed to Next Section
|